Skip to main content

Table 2 Estimated parameter values for patients 1–7

From: Personalized life expectancy and treatment benefit index of antiretroviral therapy

Par.

P1

P2

P3

P4

P5

P6

P7

β λ

117.95

107.65

152.83

136.51

109.63

109.92

116.75

β k

1542.68

1614.66

1873.36

1270.91

1476.14

1471.95

1606.20

α λ

0.32

0.13

0.44

0.31

0.08

0.08

0.04

α k

0.56

0.99

0.84

1.08

1.11

1.11

1.07

T m

4014

3946.7

4571.1

3739.2

3995

4002.1

4019.7

η

0.78

0.71

0.60

0.78

0.89

0.78

0.96

τ 50

117.89

39.34

383.85

30.23

52.64

55.92

31.76

τ m

15915

18055

4496

7574

17382

17277

20596

q

0.84

0.77

0.89

0.75

0.78

0.64

0.65

p

3.72

8.13

1.23

13.96

1.89

2.19

3.14

\(\bar {\beta }_{k}\)

73.35

1614.7

1869.7

12.70

1294.6

931.08

217.12

\(\bar {\alpha }_{k}\)

0.56

0.99

0.84

0.80

1.10

1.11

1.07

l

0.80

0.99

0.99

0.86

0.80

0.99

0.90

T s

2983.6

3681

3290.4

3358.7

3719.5

3521

3839.7

T r

3796.47

5070.56

3812.76

3929.77

5544.5

4424.67

4232.49

T e

4279.6

5116

4592.1

4038.7

4909

4615.4

6706.3

T d

18899.09

21736.01

7786.16

10932.50

21101.71

20798.12

24436.16

B CD4

200

100

200

50

  1. where Par. represents parameter, and Pi denote Patient i